Ahmedabad:  Hester Biosciences Limited, one of India’s leading animal health company, manufacturing vaccines and health products has reported consolidated revenue from operations of Rs. 67.30 crore for the Q4FY23, growth of 19% Y-o-Y from revenue of Rs. 56.47 crore in Q4FY22. Operating profit during the quarter ended March 2023 was reported at Rs. 11.67 crore, 13% growth Y-o-Y from Rs. 10.33 crore in Q4FY22.  Company has recommended dividend of Rs. 8 per equity share of Rs. 10 each (80%) for...Read More

Ahmedabad: Hester Biosciences Limited has signed an agreement towards receiving indigenously developed technology from the Indian Council of Agricultural Research - National Institute of High-Security Animal Diseases (ICAR-NIHSAD), for the development and commercialization of the Low Pathogenic Avian Influenza (H9N2 strain) Inactivated Vaccine for poultry. The agreement was signed on 27 December 2022 at the office of Agrinnovate India, New Delhi. Agrinnovate is a government entity that acts a...Read More

Ahmedabad: Gujarat headquartered Hester Biosciences Limited has reported a consolidated net profit of Rs. 3.56 crore and Revenue from Operations of Rs. 50.70 crores for the Q1FY23. Individually, the gross margins of the vaccines and the health products have been in line with the corresponding quarter, however, the overall margins have reduced due to the increase in the proportion of health products sales which have lower gross margins compared to vaccines. Health Products sales constituted 34...Read More

Gandhinagar: Shri Rajiv Gandhi, Founder, CEO & Managing Director of Gujarat headquartered Hester Biosciences has been nominated as a member of the National Advisory Committee for Animal Husbandry and Dairying Sector, constituted by The Government of India. This committee, chaired by Union Minister (FAHD) Shri Parshottam Rupalaji, has been constituted to recommend, prescribe and advise policies relating to cattle & dairy development, feed and fodder, poultry, piggery, sheep, goat and a...Read More

Gandhinagar: Gujarat headquartered Hester Biosciences Limited is all set to expand into the rapidly growing Pet Care sector this April. India has the fastest-growing pet care market worldwide, with it growing by 14% in 2022, making this an exciting and valuable opportunity for the poultry vaccine giant. Hester’s comprehensive knowledge of animal biology, cutting-edge R&D capabilities, and four-decade-long experience in animal healthcare gives them an advantage. This expansion perfectly alig...Read More

Gandhinagar: Gujarat will soon start production of a drug substance which is used for manufacturing of COVAXIN.   In the current situation of covid-19, it is required to accelerate the production of vaccine which can be made available to the people of Gujarat and India. This is possible by expanding the production of current vaccine through contract manufacturing.   Considering this, GBRC (Gujarat Biotechnology Research Centre), an autonomous society established under Department of Scienc...Read More

Gandhinagar: Gujarat headquartered Hester has signed two agreements with ICAR-IVRI (Indian Council of Agricultural Research – Indian Veterinary Research Institute),for acquiring technologies for the production and commercialisation of the following vaccines: 1. Classical Swine Fever Vaccine 2. Sheep Pox Vaccine These vaccines are the first that have been developed within the country by using locally isolated strains, a step towards making India self-sufficient, Atmanirbhar, for ...Read More

Gandhinagar: Gujarat government arm Gujarat Biotechnology Research Centre (GBRC) has signed memorandum of understanding (MoU) with three private companies of the State today to develop vaccine for Coronavirus infection. MoU with Hester Biosciences has been signed to develop Covid19 inactivated vaccine MoU with Neuberg Supratech Ltd has been signed to develop Covid19 recombinant  vaccine and diagnostics. MoU with Vekaria Healthcare LLP Ltd has been signed to develop Covid19 recombinant ...Read More

Gandhinagar: Indian Institute of Technology Guwahati has collaborated with Hester Biosciences Limited, a pharmaceutical company based in Gujarat, to work on the vaccine development against COVID-19. The agreement between the two parties was signed on 15th April 2020. A statement released by the company informs: The vaccine will be based on recombinant avian paramyxovirus based vector platform. The recombinant avian paramyxovirus-1 will be used to express the immunogenic protein of SARS-CoV-2....Read More